Literature DB >> 6786056

Parenchymal CT correlates of senile dementia (Alzheimer disease): loss of gray-white matter discriminability.

A E George, M J de Leon, S H Ferris, I I Kricheff.   

Abstract

Neuropathologic studies have defined gross anatomic (structural) as well as histologic (parenchymal) changes of senile dementia (Alzheimer disease). This investigation suggests that loss of gray-white matter discriminability by computed tomography (CT) is related to cognitive impairment in this disease. Discriminability is defined as the relative ease of visual differentiation between gray and white tissues. Twenty-six elderly patients with dementia were subjected to extensive psychometric evaluation, a medical and neurologic examination, and CT scanning. Gray and white matter changes were assessed by subjectively evaluating three brain levels, the basal ganglia, the centrum semiovale, and the high convexity, on a five point scale. Quantitated gray and white matter scores were also obtained by sampling CT attenuation values. In addition, CT structural changes were evaluated by previously reported methods. there were significant correlations (P less than 0.05) between the subjectively assessed loss of gray-white matter discriminability at all brain levels and the measures of cognitive decline. At the high convexity level 91% of cognitive measures correlated with loss of gray-white discriminability. In the same patient group no gray-white discriminability correlation with age was demonstrated suggesting that gray-white discriminability does not simply change with age.

Entities:  

Mesh:

Year:  1981        PMID: 6786056      PMCID: PMC8331507     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  6 in total

Review 1.  Brain imaging techniques in the diagnosis of dementia.

Authors:  A L Powell; D F Benson
Journal:  Neuropsychol Rev       Date:  1990-03       Impact factor: 7.444

2.  Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?

Authors:  T Erkinjuntti; L Ketonen; R Sulkava; J Sipponen; M Vuorialho; M Iivanainen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-01       Impact factor: 10.154

Review 3.  Vascular Cognitive Impairment (VCI).

Authors:  Tatjana Rundek; Magdalena Tolea; Taylor Ariko; Eric A Fagerli; Christian J Camargo
Journal:  Neurotherapeutics       Date:  2021-12-22       Impact factor: 6.088

Review 4.  Diagnostic and pharmacological approaches in Alzheimer's disease.

Authors:  C Hermann; R G Stern; M F Losonzcy; S Jaff; M Davidson
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

5.  Differentiating shunt-responsive normal pressure hydrocephalus from Alzheimer disease and normal aging: pilot study using automated MRI brain tissue segmentation.

Authors:  Yafell Serulle; Henry Rusinek; Ivan I Kirov; Hannah Milch; Els Fieremans; Alexander B Baxter; John McMenamy; Rajan Jain; Jeffrey Wisoff; James Golomb; Oded Gonen; Ajax E George
Journal:  J Neurol       Date:  2014-08-01       Impact factor: 4.849

6.  A computed tomography study of Alzheimer's disease by regional volumetric and parenchymal density measurements.

Authors:  Y Ichimiya; K Kobayashi; H Arai; K Ikeda; K Kosaka
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.